DSD-C126

Congenital adrenal hyperplasia · 46,XX · DSD-C126

DSD-C126 · Congenital adrenal hyperplasia · 2019

Genes CYP19A1 · Karyotype 46,XX

46,XX disorder of sex development — aromatase deficiency (AD). Often misdiagnosed as CAH 21-OHD. AD features: non-progressive external virilization + maternal androgen excess + delayed bone age + hypergonadotropism.

Images · 2

Case fields and evidence

Category

Congenital adrenal hyperplasia

Age

2 years 8 months (first evaluated at 6 months)

Sex

46,XX, raised as female

Karyotype

46,XX

Genetics

CYP19A1

Diagnosis

46,XX disorder of sex development — aromatase deficiency (AD). Often misdiagnosed as CAH 21-OHD. AD features: non-progressive external virilization + maternal androgen excess + delayed bone age + hypergonadotropism.

Follow-up

Annual clinical evaluation follow-up. Future risks: insulin resistance, dyslipidemia, metabolic syndrome. Estrogen replacement at puberty induction.

General phenotype

Non-palpable gonads; general examination normal.

Imaging

Hand/wrist X-ray showed delayed bone age (16 mo vs actual 28 mo); pelvic ultrasound showed infantile uterus, small ovaries without follicles; Genitogram with low-position vaginal confluence.

Laboratory findings

Karyotype: 46,XX (reference: –; time point: initial visit); FISH(SRY): negative (reference: negative; time point: both negative); 17-OHP (baseline): 2.46 ng/mL (reference: ≤1.47; time point: 6 months); 17-OHP (post-stimulation): 4.2 ng/mL (reference: <10; time point: post-tetracosactide); serum cortisol (baseline): 10.3 μg/dL (reference: 1.4–27; time point: 08:00); ACTH (baseline): 13.2 pg/mL (reference: <46; time point: frozen sample); DHEAS: 15 μg/dL (reference: <74; time point: 6 months); total testosterone (fasting): 5.47 ng/mL (reference: 2–5; time point: 08:00 fasting); FSH: 67.67/90.42 mIU/mL (reference: 0.7–3.4; time point: markedly elevated, postmenopausal level); LH: 3.06/1.8 mIU/mL (reference: ≤0.26; time point: above normal preschool values); AMH: 0.13/0.05 ng/mL (reference: <0.01; time point: very low); bone age (X-ray): 16 months (reference: actual 28 months, delayed; time point: at 2y8m); testosterone on day 5 of hCG stimulation: 14.64 ng/mL (reference: >2-fold rise = functional Leydig cells; time point: hCG stimulation); pelvic ultrasound: infantile uterus, gonads not visualized (reference: –; time point: 6 months); repeat pelvic ultrasound: uterus 1.7×0.5×0.8 cm, ovaries 5×4 mm/5×3 mm without follicles (reference: atrophic ovaries; time point: 3 years)

Management

Parents chose to continue female rearing. Regular follow-up, plan to induce puberty at ~10–12 years (estrogen replacement). Low-dose estrogen withheld for now (no ovarian cysts).

Pathology

Gonadal pathology not reported.

Evidence level

See source

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia · 46,XX · DSD-C126 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C126?version=v1.4.0